Navigation Links
Understand Your Serialization Options and the Long and Short-term Benefit of Switching Providers, Upcoming Webinar Hosted by Xtalks
Date:8/15/2019

Serialization deadlines in the US and European Union have finally passed. Now what? As serialization mandates become increasingly complex, and aggregation becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing whether their current serialization software is the best long-term solution.

Until now, most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system capabilities. In the coming months, serialization systems will be tested for their ability to handle aggregation data, facilitate integration with distribution (internal and third-party logistics providers), integrate with downstream customers and handle complicated regulatory reporting requirements, such as the European Union’s Falsified Medicines Directive (EU FMD) and the Russian Federal Law No. 425-FZ.

Many players in the pharmaceutical industry have been feeling the pain of serialization solutions that are falling short. With the largest packaging-line installation base of any vendor, OPTEL often hears about these struggles: over-promised and under-delivered capabilities; high rates of issues and bugs; and the unexpected need to pay for costly “optional” tools and third-party resources to maintain a validated, high-performing solution.

Join Ron Watkins, Product Owner at Visit OPTEL and Bill Romano, Sales and Account Executive at OPTEL in a live session on Wednesday, September 11, 2019 at 9am EDT (2pm BST/UK) to better understand serialization options for global requirements. The featured speakers will discuss tested methodology and real-life case studies, as well as the immediate and longer-term benefits of moving to the OPTEL serialization platform.

For more information or to register for this free event, visit Understand Your Serialization Options and the Long and Short-term Benefit of Switching Providers.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Candice Tang
Tel: +1 (416) 977-6555 ext 400
Email: ctang@xtalks.com

Read the full story at https://www.prweb.com/releases/understand_your_serialization_options_and_the_long_and_short_term_benefit_of_switching_providers_upcoming_webinar_hosted_by_xtalks/prweb16500340.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. BRAIN initiative seeks tools to understand human thought, behavior, consciousness
2. Divide and define: Clues to understanding how stem cells produce different kinds of cells
3. Understanding the past and predicting the future by looking across space and time
4. OHSU scientists advance understanding of brain receptor; may help fight neurological disorders
5. Understanding the hearts rhythm
6. NIH fellowship helps researcher fight malaria, understand mosquito immunity
7. Unexpected discovery of the ways cells move could boost understanding of complex diseases
8. Honey bee gene targeting offers system to understand food-related behavior
9. CU study relies on twins and their parents to understand height-IQ connection
10. Drexel researchers looking inside vessels to understand bloods ebb and flow
11. Discovery of cell division master controller may improve understanding and treatment of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... September 17, 2019 , ... VISTAAR released ADVISORY Playbooks to ... as re-assurance / 2nd opinion to their internal strategies they formed for developing or ... going into new markets, or planning to change their product elements and want to ...
(Date:9/14/2019)... ... 13, 2019 , ... Two studies presented at the annual ... of gene therapy and advances to decrease nerve damage using Fluorescence image-guided surgery. ... storage diseases (LSD) are among the most dismal of prognosis in all of ...
(Date:9/8/2019)... ... September 06, 2019 , ... ... Nanosens Innovations have each authorized the respective companies to proceed with a proposed ... with the Nanosens brand representing a series of products leveraging the CRISPR-Chip technology. ...
Breaking Biology News(10 mins):
(Date:9/30/2019)... ... September 30, 2019 , ... The September 2019 edition of ... is now available online on the company’s global website. The Bridge features current ... fluorescence and imaging, and presents articles, scientific papers and news reports. , ...
(Date:9/24/2019)... ... 24, 2019 , ... Drug resistance has been declared as one of the ... becoming one of the most serious concerns. Hong Kong cannot be spared from the ... (CA-MRSA), or a seven-fold of the figure in 2007 – the year the disease ...
(Date:9/24/2019)... ... 24, 2019 , ... Personalized Stem Cells, Inc ... for clinical trial sites and physician investigators. The clinical trial sites are ... , Clinical trial sites are currently located in San Diego and Los Angeles ...
(Date:9/24/2019)... ... September 24, 2019 , ... In the past three ... led by faculty at South Dakota School of Mines & Technology that ... that attach to surfaces to form a slimy and yet strong layer which is ...
Breaking Biology Technology: